Johnson Financial Group, Inc. Viatris Inc Transaction History

Johnson Financial Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$11.27 - $13.53 $1,510 - $1,813	-134 Reduced 90.54%	14 $0
Q4 2023 Feb 09, 2024	BUY	$8.77 - $10.85 $1,297 - $1,605	148 New	148 $1,000
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $784 - $895	-87 Reduced 70.16%	37 $0
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $745 - $993	-81 Reduced 39.51%	124 $1,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $3,671 - $4,819	-433 Reduced 67.87%	205 $2,000
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $865 - $1,067	-87 Reduced 12.0%	638 $7,000
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $10,565 - $16,585	-1,077 Reduced 59.77%	725 $8,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $6,661 - $8,088	551 Added 44.04%	1,802 $24,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $6,028 - $6,884	-455 Reduced 26.67%	1,251 $17,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $13,981 - $17,409	-1,078 Reduced 38.72%	1,706 $25,000
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $33,907 - $46,257	2,495 Added 863.32%	2,784 $40,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $4,132 - $5,415	289 New	289 $5,000

1,099

969M

2.63M

2.15M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Johnson Financial Group, Inc. with notifications on news.